Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amy Behnken
Observed names:
Amy L Behnken,
Amy L. Behnken
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5037819202
Palliative Care Clinicians Caring for Patients Before and After Continuous Flow-Left Ventricular Assist Device
2017
·
Sara E. Wordingham
, Colleen K. McIlvennan
, et al.
·
Journal of Pain and Symptom Management
·
31
PDF
Acoustic Properties of Axial and Centrifugal Flow Left Ventricular Assist Devices and Prediction of Pump Thrombosis
2021
·
Barry A. Boilson
, Elizabeth L. Bechtum
, et al.
·
Mayo Clinic Proceedings
·
9
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience
2026
·
Domitilla Baccon
, Suheil Albert Atallah-Yunes
, et al.
·
Blood Cancer Journal
·
2
PDF
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026
2026
·
Sameer A. Parikh
, Paul J. Hampel
, et al.
·
Mayo Clinic Proceedings
·
1
Progression of disease within 36 months (POD36) of starting first-line targeted therapy independently predicts poor overall survival in patients with chronic lymphocytic leukemia (CLL)
2025
·
Paul Hampel
, Kari Rabe
, et al.
·
Blood
·
1
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population
2026
·
Lauren D. Pomerantz
, Kari G. Rabe
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
Abstract 1191: Depth of immunoparesis predicts time to first therapy in newly diagnosed monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
2026
·
Yuan Yao
, Kari G. Rabe
, et al.
·
Cancer Research
Venetoclax-obinutuzumab in frontline and R/R CLL: Outcomes compared to age- and sex-matched general population
2025
·
Lauren Pomerantz
, Sameer Parikh
, et al.
·
Blood
Pirtobrutinib versus usual care for patients with richter transformation of chronic lymphocytic leukemia: Inverse probability of treatment weighting-based analysis of BRUIN trial and mayo observational cohort
2025
·
Yucai Wang
, Kari Rabe
, et al.
·
Blood
PDF
A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia
2025
·
Rachel J. Bailen
, Monica I. Aasum
, et al.
·
Journal of Oncology Pharmacy Practice
CLL-081 Impact of Multi-Hit vs Single-Hit TP53 Mutations in Chronic Lymphocytic Leukemia
2023
·
Steven Hwang
, Yucai Wang
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
PDF
POSTER: CLL-081 Impact of Multi-Hit vs Single-Hit TP53 Mutations in Chronic Lymphocytic Leukemia
2023
·
Steven Hwang
, Yucai Wang
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations
2022
·
Steven R Hwang
, Yucai Wang
, et al.
·
Blood
Show more works
View as search
Works count:
13
Citation count:
43
H-index:
2
I10-index:
1
Year
Topic
Type
